Global Embolic Protection Devices Market 2016-2020 - Product Image

Global Embolic Protection Devices Market 2016-2020

  • ID: 3795221
  • Report
  • Region: Global
  • 84 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Allium Medical
  • Biophan Technologies
  • CardiacAssist
  • Claret Medical
  • Edward Lifesciences
  • MORE
About Embolic Protection Devices

The formation of plaque in the blood vessels can cause coronary artery disease (CAD). The disease causes narrowing of the blood vessels, which interrupts normal blood flow and may lead to ischemic stroke. Physicians may implant catheters along with stents to treat the disease; however, the procedure can lead to embolism or disruption of plaque.

The plaque debris may pass into the blood flow through the carotid artery to reach the brain, which can lead to stroke and death. To prevent this, physicians use embolic protection devices to collect and remove the debris from the blood vessels while performing angioplasty and stenting procedures.

The analysts forecast the global embolic protection devices market to grow at a CAGR of 9.58% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global emblic protection devices market for 2016-2020. To calculate the market size, we consider revenue generated from the sales of embolic protection devices used for capturing and removing embolic debris in the blood lodged during stenting or angioplasty.

The market is divided into the following segments based on geography:

- Americas
- EMEA
- APAC

The report, Global Embolic Protection Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Boston Scientific
- Cardinal Health
- Medtronic

Other prominent vendors
- Abiomed
- AdvanSource Biomaterials
- AGA Medical
- Allium Medical Solutions
- AngioDynamics
- Angioslide
- Atrium Medical
- Biophan Technologies
- Biosense Webster
- Cardiac Science
- CardiacAssist
- Cardica
- Cardio Flow
- Claret Medical
- Contego Medical
- Cook Group
- Edward Lifesciences
- Innovative Cardiovascular Solutions
- Keystone Heart
- Transverse Medical

Market drivers
- Incidence of cardiac diseases and adoption of PCI

Market challenges
- High cost of stenting

Market trends
- Integrated technologies by small companies for market penetration

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Allium Medical
  • Biophan Technologies
  • CardiacAssist
  • Claret Medical
  • Edward Lifesciences
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
  • Embolic protection devices: An overview
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Global occlusion devices market
  • Global distal filter devices market
PART 07: Market segmentation by treatment procedure
  • Global embolic protection devices market for coronary artery treatment
  • Global embolic protection devices for carotid artery treatment
  • Global embolic protection devices for peripheral artery treatment
PART 08: Market segmentation by end-users
  • ASCs
  • Hospitals
  • Physicians' offices
PART 09: Geographical segmentation
  • Embolic protection devices market in Americas
  • Embolic protection devices market in EMEA
  • Embolic protection devices market in APAC
PART 10: Market drivers
  • Incidence of cardiac diseases and adoption of PCI
  • Outsourcing PCI device research to CROs
  • Venture capitals for market entry of start-ups
  • Minimally invasive procedures with improved medical imaging
PART 11: Impact of drivers

PART 12: Market challenges
  • High cost of stenting
  • Product recalls
  • Lack of product differentiation leading to marginal profits
PART 13: Impact of drivers and challenges

PART 14: Market trends
  • Integrated technologies by small companies for market penetration
  • Emergence of digital cath-labs in hospitals
  • Transforming marketing and sales strategies for embolic protection devices
PART 15: Vendor landscape
  • Competitive scenario
PART 16: Major vendors
  • Abbott Laboratories
  • Boston Scientific
  • Cardinal Health
  • Medtronic
  • Other prominent vendors
PART 17: Appendix
  • List of abbreviations
PART 18: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Embolic protection devices: Clinical studies with positive results
Exhibit 03: Global embolic protection devices market: New entrants
Exhibit 04: Scope of embolic protection devices in various regions 2016-2020
Exhibit 05: Global embolic protection devices market: Impact assessment
Exhibit 06: Global embolic protection devices market 2015-2020 ($ millions)
Exhibit 07: Global embolic protection devices market: Metrics analysis
Exhibit 08: Five forces analysis
Exhibit 09: Global embolic protection devices market segmentation by product 2015
Exhibit 10: Global balloon occlusion devices market: Metrics analysis
Exhibit 11: Global distal filter devices market: Metrics analysis
Exhibit 12: Global embolic protection devices market segmentation by treatment procedure 2015
Exhibit 13: Global embolic protection devices market for coronary artery treatment: Market overview
Exhibit 14: Global embolic protection devices for carotid artery treatment: Market overview
Exhibit 15: Global embolic protection devices for peripheral artery treatment: Market overview
Exhibit 16: Global embolic protection devices market segmentation by end-user 2015
Exhibit 17: Comparison of reimbursement for ASCs, hospital outpatient departments, and physicians' offices in US
Exhibit 18: Coronary angioplasty same day basis procedure in hospitals and ASCs in Europe
Exhibit 19: Global embolic protection devices market segmentation by geography 2015
Exhibit 20: Global embolic protection devices market segmentation by geography 2020
Exhibit 21: Global embolic protection devices market segmentation by geography 2015-2020
Exhibit 22: Global embolic protection devices market segmentation by geography 2015-2020 ($ millions)
Exhibit 23: Number of coronary angiography procedures in few countries in Americas 2013
Exhibit 24: Embolic protection devices market in Americas 2015-2020 ($ millions)
Exhibit 25: Embolic protection devices market in the Americas: Metrics analysis for various countries
Exhibit 26: Implements amended in ACA in US
Exhibit 27: Impact of ACO and ACA on embolic protection devices
Exhibit 28: Embolic protection devices in EMEA: Market overview
Exhibit 29: Number of coronary revascularization procedures per 100,000 people in various countries in EMEA 2013
Exhibit 30: Number of coronary angiography procedures in various countries in EMEA 2006 and 2013
Exhibit 31: Embolic protection devices market in EMEA 2015-2020 ($ millions)
Exhibit 32: Embolic protection devices market in APAC: Market overview
Exhibit 33: Embolic protection devices market in APAC 2015-2020 ($ millions)
Exhibit 34: CROs that helped companies receive regulatory approvals for PCI devices
Exhibit 35: New market entrants
Exhibit 36: Impact of drivers
Exhibit 37: Product recalls: Embolic protection devices and stents
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Some advanced embolic protection devices
Exhibit 40: Marketing and sales strategies of large and small companies
Exhibit 41: Global embolic protection devices market: Competitive landscape analysis 2015
Exhibit 42: Global market penetration of various companies 2015
Exhibit 43: Abbott Laboratories: Metrics analysis
Exhibit 44: Boston Scientific: Metrics analysis
Exhibit 45: Cardinal Health: Metrics analysis
Exhibit 46: Medtronic: Metrics analysis
Exhibit 47: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Allium Medical
  • Biophan Technologies
  • CardiacAssist
  • Claret Medical
  • Edward Lifesciences
  • MORE
New Report Released: - Global Embolic Protection Devices Market 2016-2020

The author of the report recognizes the following companies as the key players in the global embolic protection devices market: Abbott Laboratories, Boston Scientific, Cardinal Health, and Medtronic.

Other Prominent Vendors in the market are: Abiomed, Advansource Biomaterials, AGA Medical, Allium Medical, AngioDynamics, AngioSlide, Atrium Medical, Biophan Technologies, Biosense Webster, Cardiac Science, CardiacAssist, Cardica, Cardio-Flow, Claret Medical, Contego Medical, Cook Group, Cryolife, Edward Lifesciences, Innovative Cardiovascular Solutions, Keystone Heart, and Transverse Medical.

Commenting on the report, an analyst from the research team said: “Integrated technologies by small companies for market penetration is a key trend for this market. Small companies develop advanced technologies to enter the market. Until date, only a few products are in their development stage or have received regulatory approval only in one region. These products are highly advanced and specific to the preference of physicians. Post approval, these advanced devices can pose a threat to large companies such as Medtronic and Boston Scientific.”

According to the report, incidence of cardiac diseases and adoption of PCI is a key driver for this market. The incidence of cardiac diseases is on the rise worldwide. In 2015, the CDC estimated that these diseases caused about 610,000 deaths in the US. The organization also estimates that coronary heart disease was the most common cardiac disease, causing 375,000 deaths in the US annually. To treat these diseases, physicians diagnose and may recommend surgeries based on their stage.

Further, the report states that high cost of stenting is a challenge to market growth. The demand for and use of embolic protection devices is low in many countries due to the high cost of stenting. The overall cost associated with stenting varies among hospitals based on the stent procedure, patient care, and hospital stay. The overall cost associated with stenting can be $12,000-$38,000, with the average price of the stents being $2,000-$4,500. The price of stents may further increase depending on the type of advanced technology used. The stenting procedure costs $7,000-$28,000.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Abbott Laboratories
- Boston Scientific
- Cardinal Health
- Medtronic
- Abiomed
- Advansource Biomaterials
- AGA Medical
- Allium Medical
- AngioDynamics
- AngioSlide
- Atrium Medical
- Biophan Technologies
- Biosense Webster
- Cardiac Science
- CardiacAssist
- Cardica
- Cardio-Flow
- Claret Medical
- Contego Medical
- Cook Group
- Cryolife
- Edward Lifesciences
- Innovative Cardiovascular Solutions
- Keystone Heart
- Transverse Medical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll